oxazolidin-2-one has been researched along with Ache in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brignardello-Petersen, R | 1 |
| Hu, T; Li, Y; Lin, F; Liu, X; Lu, C; Qiu, Y; Ren, J; Wu, K; Wu, Y; Xiang, L; Xiu, Y; Yang, Y; Zhou, P | 1 |
| Best, C; Birklein, F; Döring, K; Krämer, HH | 1 |
| Assaid, C; Dodick, DW; Ho, TW; Kost, J; Lines, C | 1 |
| Dodick, DW; Ferrari, MD; Ho, TW; Kost, J; Lines, C; Olesen, J | 1 |
| Barber, GR; Barron, MA; Go, AC; Golightly, LK | 1 |
| Cucurachi, L; Sperber, SA | 1 |
| Aubel, B; Bourgoin, S; Hamon, M; Kayser, V | 1 |
| Burstein, R; Collins, B; Jakubowski, M | 1 |
| Akguen, D; Baykal, O; Diener, HC; Katsarava, Z; Kaube, H; Limmroth, V | 1 |
| Charlesworth, B; Klapper, J; Lucas, C; Røsjø, Ø | 1 |
| Abu-Shakra, S; Adelman, J; Freitag, FG; Loder, E; Pearlmand, S | 1 |
| Chang, YC; Chao, CC; Hsieh, ST; Sun, HY | 1 |
| Crain, GM; Gelber, DA; Jung, S; Markwell, SJ; Pfeifer, MA; Ross, DR; Schrage, JP; Schumer, MP | 1 |
| Goadsby, PJ; Hoskin, KL | 1 |
| Dent, RW; Ervin, DK | 1 |
8 trial(s) available for oxazolidin-2-one and Ache
| Article | Year |
|---|---|
Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Electric Stimulation; Female; Humans; Male; Migraine Disorders; Neurogenic Inflammation; Neurons, Afferent; Nociceptors; Oxazolidinones; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Serotonin Receptor Agonists; Skin; Tryptamines; Young Adult | 2015 |
Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
Topics: Adult; Analgesics; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Pain; Research Design; Serotonin 5-HT1 Receptor Antagonists; Tryptamines | 2011 |
Antimigraine efficacy of telcagepant based on patient's historical triptan response.
Topics: Adult; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Double-Blind Method; Female; Humans; Imidazoles; Male; Migraine Disorders; Oxazolidinones; Pain; Surveys and Questionnaires; Tryptamines | 2011 |
Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blinking; Electrophysiology; Female; Humans; Male; Migraine without Aura; Oxazolidinones; Pain; Pain Measurement; Serotonin Receptor Agonists; Trigeminal Nerve; Tryptamines | 2004 |
Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
Topics: Activities of Daily Living; Adolescent; Adult; Aged; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Migraine Disorders; Odds Ratio; Oxazolidinones; Pain; Prospective Studies; Time Factors; Tryptamines | 2004 |
Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
Topics: Acute Disease; Administration, Oral; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Oxazolidinones; Pain; Placebos; Serotonin Receptor Agonists; Treatment Outcome; Tryptamines | 2005 |
A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.
Topics: Analgesics; Capsaicin; Diabetic Neuropathies; Exercise Therapy; Female; Glycated Hemoglobin; Humans; Imipramine; Male; Mexiletine; Middle Aged; Models, Neurological; Muscles; Oxazoles; Oxazolidinones; Pain; Pain Management; Pain Measurement; Piroxicam | 1993 |
A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study.
Topics: Anthropometry; Clinical Trials as Topic; Drug Evaluation; Humans; Inflammation; Muscular Diseases; Oxazoles; Oxazolidinones; Pain; Placebos; Spasm; Wounds and Injuries | 1975 |
8 other study(ies) available for oxazolidin-2-one and Ache
| Article | Year |
|---|---|
Treating dentin hypersensitivity of noncarious lesions with chemical occlusion, physical occlusion, and nerve desensitization probably reduces pain, but there is not sufficient evidence to determine which agent is better.
Topics: Dentin; Dentin Desensitizing Agents; Dentin Sensitivity; Humans; Oxazolidinones; Pain | 2018 |
N-Acylethanolamine acid amidase (NAAA) inhibitor F215 as a novel therapeutic agent for osteoarthritis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Cartilage; Cells, Cultured; Chondrocytes; Ethanolamines; Injections, Intra-Articular; Injections, Intraperitoneal; Interleukin-6; Knee Joint; Male; Matrix Metalloproteinase 13; Osteoarthritis; Oxazolidinones; Pain; Palmitic Acids; PPAR alpha; Pyrrolidines; Rats, Sprague-Dawley; Spinal Cord | 2019 |
Linezolid interaction with serotonin reuptake inhibitors: report of two cases and incidence assessment.
Topics: Acetamides; Anti-Infective Agents; Citalopram; Drug Interactions; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pain; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Staphylococcal Infections; Tremor | 2010 |
Meningococcemia presenting as acute painful mononeuritis multiplex.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Electrodiagnosis; Electromyography; Female; Fever; Humans; Linezolid; Meningococcal Infections; Mononeuropathies; Neisseria meningitidis; Neural Conduction; Neurologic Examination; Oxazolidinones; Pain; Sepsis; Sural Nerve | 2012 |
The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Male; Migraine Disorders; Oxazolidinones; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Nerve Diseases; Tryptamines | 2002 |
Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
Topics: Administration, Oral; Adolescent; Adult; Humans; Injections; Middle Aged; Migraine Disorders; Oxazolidinones; Pain; Pain Measurement; Prospective Studies; Serotonin Receptor Agonists; Skin; Sumatriptan; Time Factors; Triazoles; Tryptamines | 2004 |
Painful neuropathy with skin denervation after prolonged use of linezolid.
Topics: Acetamides; Anti-Infective Agents; Biopsy; Epidermis; Female; Humans; Linezolid; Middle Aged; Neural Conduction; Oxazolidinones; Pain; Sensory Receptor Cells; Skin; Streptococcal Infections; Time Factors | 2008 |
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Topics: Animals; Cats; Cerebrovascular Circulation; Cranial Sinuses; Electric Stimulation; Gene Expression Regulation; Genes, fos; Migraine Disorders; Neurons, Afferent; Nociceptors; Oxazoles; Oxazolidinones; Pain; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Synaptic Transmission; Trigeminal Caudal Nucleus; Trigeminal Nerve; Trigeminal Nucleus, Spinal; Tryptamines; Vasoconstrictor Agents | 1998 |